Physician profile
Kelly A Fields
NPI 1306828181
$2,058.19
in general payments reported to CMS, 2019-2025
22 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $511 · 2023: $304 · 2024: $392 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,233.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $400.64 | 2022-2025 | |
| Novo Nordisk INC | $375.13 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $308.45 | 2022-2025 | Rexulti |
| Boston Scientific Corporation | $149.46 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $137.18 | 2024 | Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $132.53 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $96.33 | 2021 | |
| Coloplast Corp | $82.45 | 2023 | Titan |
| Tactile Systems Technology INC | $60.00 | 2021 | |
| Phathom Pharmaceuticals, INC. | $52.11 | 2024 | Voquezna |
| Medtronic, INC. | $44.42 | 2021-2025 | Kyphon Express II Kyphopak Tray |
| Novartis Pharmaceuticals Corporation | $35.40 | 2025 | |
| Ethicon US, LLC | $27.01 | 2021 | |
| Organogenesis INC. | $23.52 | 2021 | |
| Pfizer INC. | $23.17 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $20.63 | 2025 | Keveyis |
| Paratek Pharmaceuticals, INC. | $18.60 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.13 | 2025 | Spravato |
| Coopersurgical, INC. | $14.90 | 2025 | Paragard T 380a |
| Myriad Genetic Laboratories, INC. | $13.87 | 2021 | |
| Kci USA, INC. | $13.05 | 2021 | |
| Lilly USA, LLC | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelly Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.